FDAnews
www.fdanews.com/articles/206673-novacyts-direct-to-pcr-covid-19-test-approved-in-the-uk

Novacyt’s Direct-to-PCR COVID-19 Test Approved in the UK

February 22, 2022

Novacyt said its PROmate COVID-19 2G polymerase chain-reaction (PCR) test has been approved for use in the UK.

The Anglo-French company, which has offices in Camberley, UK, and Paris, France, received UK approval for another real-time PCR test, COVID-19 genesig, in November 2021.

The PROmate test can detect two different SARS-CoV-2 genetic targets. The new test responds to the increased demand for multi-gene testing solutions that can identify multiple variants of the SARS-CoV-2 virus, the company said.

Novacyt said the new test is suitable for use in travel, sport, film, media and workplace settings.

View today's stories